WALTHAM, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...
The growth of the market for Neoantigen cancer vaccines is primarily attributable to rapid technological advancements and improvements in the healthcare...
Sath Shukla, current Spero Chief Financial Officer, will bring more than 20 years of strategic and financial leadership to the role of CEO, to be effective...
WALTHAM, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a clinical-stage biopharmaceutical company on a mission to protect the...
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
To be held on November 17, 2022
Dear Shareholder:
We cordially invite you to attend the Annual... | October 5, 2022
NOTICE OF
ANNUAL AND EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
ON
NOVEMBER 4, 2021
Notice is hereby given that an Annual and... | September 30, 2021
ET ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Q4 2020 Earnings Conference Call February 25, 2021, 04:30 PM ET Company Participants Adam Levy - Executive Vice President, Investor Relations and...